Lipid Metabolism–Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer
International Journal of Genomics · 2026-01 · 2026 (1)
DOI: 10.1155/ijog/9661210 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 17.05.2026. Verfasst von Tianze Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary, Pancreatic, Spleen, and Thyroid Surgery, General Hospital of Northern Theater Command of the Chinese People's Liberation…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Background
Altered lipid metabolism is increasingly recognized as a driver of tumor progression, yet its specific role in thyroid cancer remains unclear.
Methods
We combined Mendelian randomization with transcriptomic and single‐cell analyses to identify lipid‐related factors that contribute to thyroid cancer development. A lipid‐metabolism gene signature was constructed to evaluate its prognostic value, and functional assays were used to examine the biological role of ACBD7.
Results
Lipid‐related metabolites showed genetic evidence of causal relevance to thyroid cancer. We identified a set of lipid‐metabolism genes that were consistently dysregulated in tumors and developed a nine‐gene signature that stratified patient prognosis with high accuracy. The high‐risk group displayed stronger lipid pathway activation, a distinct immune landscape, and a higher BRAF mutation rate. ACBD7 knockdown reduced thyroid cancer cell growth, invasion, and migration, suggesting a functional link between lipid metabolism and tumor aggressiveness.
Conclusions
Lipid metabolic dysregulation contributes to thyroid cancer progression and may help refine clinical risk assessment. The nine‐gene signature and the functional relevance of ACBD7 highlight the potential of lipid‐targeted strategies in future therapeutic development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary, Pancreatic, Spleen, and Thyroid Surgery, General Hospital of Northern Theater Command of the Chinese People's Liberation Army, Shenyang, 110000, China.
- Department of General Surgery, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, China.
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Wang, T., Nan, B., Sa, Q., Xu, N., & Zhang, W. (2026). Lipid Metabolism–Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/9661210
Vancouver
Wang T, Nan B, Sa Q, Xu N, Zhang W. Lipid Metabolism–Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/9661210
BibTeX
@article{Wang2026,
author = {Wang, Tianze and Nan, Boyuan and Sa, Qila and Xu, Ning and Zhang, Wei},
title = {Lipid Metabolism–Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer},
journal = {International Journal of Genomics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijog/9661210}
}
EUVIMED